• Home
• Neueste Nachrichten
• Ad-Hoc Nachrichten
• Meinungen
• Top / Flop Kurse
• Quellen
• Virtuelles Depot
• Aktienalerts

• Intraday
• 7d
• 14d
• 1m
• 6m
• 1y

Qiagen Aktie

PRESS RELEASE: QIAGEN Launches New Automated Modular Testing Platform for Molecular Diagnostics PRESS RELEASE: QIAGEN Launches New Automated Modular Testing Platform for Molecular Diagnostics Qiagen N.V. / QIAGEN Launches New Automated Modular Testing Platform for Molecular Diagnostics processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. QIAsymphony RGQ System scores with highest possible flexibility and the broadest available range of PCR-based test systems Hilden, Germany, and Germantown, MD., September 1, 2010 - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched its novel QIAsymphony RGQ system. The automated platform has been specifically designed to address the fast-growing molecular diagnostics market, particularly for applications in "Profiling" and "Personalized Healthcare"*. It is the only modular system that covers entire laboratory workflows from the initial sample preparation to the final result. The QIAsymphony RGQ thereby provides its users with an unprecedented level of flexibility: Customers can use the new platform not only to run several existing QIAGEN tests, but also to develop and conduct their own PCR-based assays. The QIAsymphony RGQ system is approved for in-vitro diagnostic use in Europe and launches with several molecular assays for the detection of viruses such as HIV and Hepatitis, as well as a specific test panel for transplantation medicine. All of these products from QIAGEN's artus product range have been already validated for clinical use in connection with the new system.* Numerous other products will complement the existing test portfolio over the next months. These products will include tests for biomarkers such as KRAS, EGFR or PI3K in personalized healthcare applications, assays for the detection of influenza v... Weiter

© 1996-2010 stockwatch.de - Ihre Finanznachrichten - DAX 30 – stockwatch.de übernimmt keine Haftung für die Richtigkeit der Angaben